Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
CTEV · 10-Q filed August 7, 2026

CTEV earnings analysis

What we found in CTEV's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

Claritev delivered solid top-line growth, with Q2 revenue up 6.6% year over year to $257.478M, led by a 13.7% increase in Claims intelligence solutions. Gross and operating margins improved sharply from Q1 2026, but gross margin remained below the prior-year level and GAAP EPS was still negative at $3.49. Liquidity is constrained by $27.7M of cash and restricted cash against substantial debt and $100.253M of quarterly interest expense, while the DOJ civil investigation and unremediated IT control weaknesses remain significant overhangs.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Revenue Growth Accelerated
Revenue increased to $257.478M, up $15.908M or 6.6% year over year, and approximately 5.1% from $245M in Q1 2026. Six-month revenue rose 6.2% to $502.156M.
Margins Rebounded Sequentially
Gross margin was 73.72%, versus 74.8% in Q2 2025 but up from 71.8% in Q1 2026. Operating margin improved to 9.09%, versus 6.9% year over year and 2.7% in Q1 2026.
Claims Intelligence Drove Growth
Claims intelligence revenue grew $21.499M, or 13.7%, to $178.465M, driven primarily by Data iSight and Surprise Bill Services. The segment represented approximately 69.3% of quarterly revenue.
GAAP Loss Narrowed
GAAP net loss improved to $59.226M from $62.640M year over year, while diluted EPS improved to negative $3.49 from negative $3.81 and negative $4.41 in Q1 2026.
Operating Cash Flow Improved
Six-month operating cash flow increased to $46.892M from $31.181M. Management attributed the $15.7M improvement primarily to favorable deferred-income-tax changes, partially offset by working-capital effects.
Adjusted EBITDA Increased
Adjusted EBITDA increased to $155.799M from $154.028M year over year, and adjusted EPS was $1.41 versus $1.44, despite $9.250M of quarterly transformation costs and $2.572M of antitrust-related legal expenses.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

IT Control Weaknesses Persist
The company reported that disclosure controls were not effective as of June 30, 2026 because material weaknesses in IT general controls remained unremediated. The deficiencies involve program-change management and user-access controls; remediation is expected to be completed during fiscal 2026.
DOJ Civil Investigation Continues
A DOJ civil investigative demand received on May 19, 2026 remains outstanding, and the company stated it cannot predict the investigation's outcome or potential consequences. The company incurred $2.572M of antitrust-related legal expenses in Q2 and $11.182M in the first six months; the separate criminal grand-jury proceeding was officially closed on July 6, 2026.
High Client Concentration
One client accounted for 35.0% of revenue in the quarter, creating significant customer-concentration exposure. Management states that losing one or more large clients could materially adversely affect results.
Heavy Interest Burden
Interest expense was $100.253M in Q2 and $199.795M for the first six months, with six-month expense up 4.4% year over year due primarily to higher average indebtedness from PIK interest charges.
Limited Cash Cushion
Cash, including restricted cash, was only $27.7M at June 30, 2026, comprising $14.4M of cash and cash equivalents and $13.3M of restricted cash. The company had $70.0M drawn on its revolver and $6.4M of outstanding letters of credit.
Transformation Raises Investment Needs
Investing cash use increased to $84.847M for the first six months from $63.489M, a $21.4M deterioration, primarily because of increased technology investment supporting transformation initiatives.
The numbers

What they reported.

What the company itself reported, taken out of the document.

What survived to operating profit
Of every $100 of revenue Cost of sales $26 Operating expenses $65 Left as operating profit $9
Percentages of revenue, taken from the filing. Drawn this way because it holds whatever scale the company reports in.
Earnings per share
$-3.49
Gross margin
73.72%
Operating margin
9.09%
Segment
Claims intelligence solutions: $178.465M, up 13.7% year over year; six-month revenue $344.770M, up 11.1%.
Segment
Network solutions: $50.333M, down 7.0% year over year; six-month revenue $97.809M, down 3.2%.
Segment
Payment and revenue integrity solutions: $28.680M, down 5.9% year over year; six-month revenue $59.577M, down 3.1%.
Guidance

What they said about what is next.

The 10-Q provides no new quantitative revenue or EPS guidance. The last disclosed full-year revenue outlook was $985M-$1.0B in the July 6, 2026 8-K; no change to that outlook is stated in this filing.

How we read the filing overall

The filing reads worse than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-Q · May 7, 2026
Claritev Corporation's Q1 2026 report shows a revenue increase of 5.8% year-over-year, totaling $244.7 million, while EPS decreased to a loss of $4.41, missing analyst estimates. The company experienced challenges with…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing CTEV makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever